A. Lehnhardt

984 total citations
23 papers, 559 citations indexed

About

A. Lehnhardt is a scholar working on Nephrology, Transplantation and Molecular Biology. According to data from OpenAlex, A. Lehnhardt has authored 23 papers receiving a total of 559 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Nephrology, 8 papers in Transplantation and 5 papers in Molecular Biology. Recurrent topics in A. Lehnhardt's work include Renal Transplantation Outcomes and Treatments (8 papers), Renal Diseases and Glomerulopathies (5 papers) and Cytomegalovirus and herpesvirus research (3 papers). A. Lehnhardt is often cited by papers focused on Renal Transplantation Outcomes and Treatments (8 papers), Renal Diseases and Glomerulopathies (5 papers) and Cytomegalovirus and herpesvirus research (3 papers). A. Lehnhardt collaborates with scholars based in Germany, United States and United Kingdom. A. Lehnhardt's co-authors include Markus J. Kemper, Markus J. Kemper, Lars Pape, G. Offner, Michael van Husen, Jun Oh, Kirsten Møller, Björn Nashan, Michael Mengel and J. Strehlau and has published in prestigious journals such as Kidney International, Transplantation and Bone.

In The Last Decade

A. Lehnhardt

22 papers receiving 550 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Lehnhardt Germany 13 184 147 139 128 118 23 559
Karine Brochard France 12 124 0.7× 96 0.7× 248 1.8× 202 1.6× 181 1.5× 23 794
K.-H. Shu Taiwan 12 144 0.8× 87 0.6× 149 1.1× 97 0.8× 85 0.7× 38 493
Vincent Pernin France 11 216 1.2× 106 0.7× 106 0.8× 151 1.2× 121 1.0× 29 623
G Rifle France 16 131 0.7× 165 1.1× 107 0.8× 67 0.5× 87 0.7× 70 580
O Otsubo Japan 14 174 0.9× 40 0.3× 108 0.8× 100 0.8× 55 0.5× 38 512
Takeshi Fujita Japan 12 86 0.5× 68 0.5× 74 0.5× 65 0.5× 97 0.8× 47 421
Kristien J. Ledeganck Belgium 14 126 0.7× 73 0.5× 304 2.2× 313 2.4× 186 1.6× 34 830
Julien Aniort France 10 164 0.9× 61 0.4× 84 0.6× 50 0.4× 83 0.7× 36 379
Atsumi Harada Japan 15 242 1.3× 69 0.5× 64 0.5× 22 0.2× 127 1.1× 45 504
Abdul Abdellatif United States 13 133 0.7× 52 0.4× 82 0.6× 42 0.3× 42 0.4× 31 356

Countries citing papers authored by A. Lehnhardt

Since Specialization
Citations

This map shows the geographic impact of A. Lehnhardt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lehnhardt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lehnhardt more than expected).

Fields of papers citing papers by A. Lehnhardt

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lehnhardt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lehnhardt. The network helps show where A. Lehnhardt may publish in the future.

Co-authorship network of co-authors of A. Lehnhardt

This figure shows the co-authorship network connecting the top 25 collaborators of A. Lehnhardt. A scholar is included among the top collaborators of A. Lehnhardt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Lehnhardt. A. Lehnhardt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sadowski, Carolin E., Kirsten Møller, Michael van Husen, et al.. (2015). Response to cyclosporine in steroid-resistant nephrotic syndrome: discontinuation is possible. Pediatric Nephrology. 30(9). 1477–1483. 21 indexed citations
2.
Grabhorn, Enke, Thomas M. C. Binder, Denise Obrecht, et al.. (2015). Long-term Clinical Relevance of De Novo Donor-Specific Antibodies After Pediatric Liver Transplantation. Transplantation. 99(9). 1876–1881. 45 indexed citations
3.
Koch, Martina, Thorsten Wiech, Matthias Marget, et al.. (2015). De novo mTOR inhibitor‐based immunosuppression in ABO‐incompatible kidney transplantation. Clinical Transplantation. 29(11). 1021–1028. 14 indexed citations
4.
Kemper, Markus J., et al.. (2014). Febrile Uriniary Tract Infections (fUTI) After Pediatric Kidney Transplantation (pKTx): A Prospective Multicenter Study.. Transplantation. 98. 118–118. 1 indexed citations
5.
Loos, Sebastian, Dirk Horstmann, Frank Donnerstag, et al.. (2014). Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome. Pediatric Nephrology. 29(9). 1607–1615. 26 indexed citations
6.
Kemper, Markus J., et al.. (2013). Is rituximab effective in childhood nephrotic syndrome? Yes and no. Pediatric Nephrology. 29(8). 1305–1311. 22 indexed citations
7.
Koch, Martina, A. Lehnhardt, Xianwen Hu, et al.. (2013). Isogeneic MSC application in a rat model of acute renal allograft rejection modulates immune response but does not prolong allograft survival. Transplant Immunology. 29(1-4). 43–50. 24 indexed citations
8.
Brinkert, Florian, A. Lehnhardt, Carmen Montoya, et al.. (2013). Combined liver-kidney transplantation for children with autosomal recessive polycystic kidney disease (ARPKD): indication and outcome. Transplant International. 26(6). 640–650. 20 indexed citations
9.
Büscher, Rainer & A. Lehnhardt. (2013). Nierenersatztherapie im Kindesalter. Monatsschrift Kinderheilkunde. 161(11). 995–1003. 2 indexed citations
10.
Koch, Martina, A. Lehnhardt, Jörg M. Pollok, et al.. (2013). Four-year allograft survival in a highly sensitized combined liver-kidney transplant patient despite unsuccessful anti-HLA antibody reduction with rituximab, splenectomy, and bortezomib. Transplant International. 26(8). e64–e68. 7 indexed citations
11.
Lehnhardt, A., et al.. (2012). Pierson syndrome in an adolescent girl with nephrotic range proteinuria but a normal GFR. Pediatric Nephrology. 27(5). 865–868. 16 indexed citations
12.
Husen, Michael van, A. Lehnhardt, Florian Brinkert, et al.. (2012). Fibroblast growth factor 23 and calcium phosphate homeostasis after pediatric renal transplantation. Pediatric Transplantation. 16(5). 443–450. 5 indexed citations
13.
Lehnhardt, A., Michael van Husen, Sebastian Loos, et al.. (2012). Elevated serum levels of B-cell activating factor in pediatric renal transplant patients. Pediatric Nephrology. 27(8). 1389–1395. 12 indexed citations
14.
Brinkert, Florian, A. Lehnhardt, K. Helmke, et al.. (2012). Combined Liver-Kidney Transplantation for Children with Autosomal Recessive Polycystic Kidney Disease. Transplantation. 94(10S). 1199–1199.
15.
Lehnhardt, A. & Markus J. Kemper. (2010). Pathogenesis, diagnosis and management of hyperkalemia. Pediatric Nephrology. 26(3). 377–384. 166 indexed citations
16.
Husen, Michael van, et al.. (2010). Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney International. 78(2). 200–206. 57 indexed citations
17.
Böckenhauer, Detlef, William van’t Hoff, Mehul Dattani, et al.. (2010). Secondary Nephrogenic Diabetes Insipidus as a Complication of Inherited Renal Diseases. Nephron Physiology. 116(4). p23–p29. 45 indexed citations
18.
Lehnhardt, A., et al.. (2006). Nodular B-Cell Aggregates Associated with Treatment Refractory Renal Transplant Rejection Resolved by Rituximab. American Journal of Transplantation. 6(4). 847–851. 54 indexed citations
19.
Lehnhardt, A., et al.. (2004). Laparoscopic fenestration of posttransplant lymphoceles in children. Journal of Pediatric Surgery. 39(8). 1230–1232. 7 indexed citations
20.
Pape, Lars, et al.. (2003). Cyclosporin A monitoring by 2‐h levels: preliminary target levels in stable pediatric kidney transplant recipients. Clinical Transplantation. 17(6). 546–548. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karine Brochard Breakdown of academic impact, for papers by K.-H. Shu Breakdown of academic impact, for papers by Vincent Pernin Breakdown of academic impact, for papers by G Rifle Breakdown of academic impact, for papers by O Otsubo Breakdown of academic impact, for papers by Takeshi Fujita Breakdown of academic impact, for papers by Kristien J. Ledeganck Breakdown of academic impact, for papers by Julien Aniort Breakdown of academic impact, for papers by Atsumi Harada Breakdown of academic impact, for papers by Abdul Abdellatif
Rankless by CCL
2026